China, India, S. Korea Seen Key Sites For Third Of Sanofi-Aventis Sales
This article was originally published in PharmAsia News
Executive SummaryChina and other emerging markets are expected to produce about a third of the income of French drug maker Sanofi-Aventis, the company said
You may also be interested in...
San Francisco-based digital health start-up Steady Health has launched the first "virtual" full-service diabetes clinic for patients in California. See what Henrik Berggren, CEO and founder of Steady Health, said about it here.
The first phase of a major trade agreement just signed by the US and China obliges the latter to implement a system linking pharma patent enforcement to marketing authorization procedures as well as to offer patent-term extensions.
Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.